ArticleFrontiers in immunology2025

Combination of cadonilimab (PD-1/CTLA-4 bispecific antibody) and apatinib as salvage therapy achieves partial response in MSI-H advanced gastric cancer: a case report.

Jiayu Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.